HK1167662A1 - Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids - Google Patents

Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids

Info

Publication number
HK1167662A1
HK1167662A1 HK12108236.3A HK12108236A HK1167662A1 HK 1167662 A1 HK1167662 A1 HK 1167662A1 HK 12108236 A HK12108236 A HK 12108236A HK 1167662 A1 HK1167662 A1 HK 1167662A1
Authority
HK
Hong Kong
Prior art keywords
aids
microparticles
secretion
inhibiting
cancer
Prior art date
Application number
HK12108236.3A
Other languages
English (en)
Chinese (zh)
Inventor
文森特．克雷格．邦德
邁克爾．鮑威爾
銘博．黃
賽義德．阿里
安德烈亞．
．雷蒙德
馬丁．內維爾．謝爾頓
弗朗索瓦．琼．菲林格爾
Original Assignee
文森特．克雷格．邦德
邁克爾．鮑威爾
銘博．黃
賽義德．阿里
安德烈亞．
．雷蒙德
馬丁．內維爾．謝爾頓
弗朗索瓦．琼．菲林格爾
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 文森特．克雷格．邦德, 邁克爾．鮑威爾, 銘博．黃, 賽義德．阿里, 安德烈亞．, ．雷蒙德, 馬丁．內維爾．謝爾頓, 弗朗索瓦．琼．菲林格爾 filed Critical 文森特．克雷格．邦德
Publication of HK1167662A1 publication Critical patent/HK1167662A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12108236.3A 2009-06-12 2012-08-22 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids HK1167662A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21347109P 2009-06-12 2009-06-12
US12/783,829 US8431530B2 (en) 2009-06-12 2010-05-20 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
PCT/US2010/035698 WO2010144231A2 (en) 2009-06-12 2010-05-21 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles

Publications (1)

Publication Number Publication Date
HK1167662A1 true HK1167662A1 (en) 2012-12-07

Family

ID=43306940

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12108236.3A HK1167662A1 (en) 2009-06-12 2012-08-22 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids

Country Status (7)

Country Link
US (5) US8431530B2 (xx)
EP (1) EP2440570B1 (xx)
JP (1) JP2012529293A (xx)
CN (1) CN102482325B (xx)
CA (1) CA2761121A1 (xx)
HK (1) HK1167662A1 (xx)
WO (1) WO2010144231A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669226B2 (en) * 2011-10-07 2014-03-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
WO2013052058A1 (en) * 2011-10-07 2013-04-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
US12083158B2 (en) 2011-10-07 2024-09-10 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
WO2013090556A1 (en) * 2011-12-13 2013-06-20 The Ohio State University Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis
US10702581B2 (en) 2015-05-04 2020-07-07 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
EP3356522A4 (en) * 2016-09-30 2019-03-27 Cellex Life Sciences, Incorporated PROTEIN-PROTECTED EXOSOME-CONTAINING COMPOSITIONS AND METHODS FOR PREPARING AND ADMINISTERING SAME
US10800817B2 (en) 2016-12-19 2020-10-13 Morehouse School Of Medicine Compositions and methods for treating diseases by inhibiting exosome release
WO2018118015A1 (en) * 2016-12-19 2018-06-28 Morehouse School Of Medicine Compositions and methods for treating diseases by inhibiting exosome release
EP3630180A1 (en) 2017-06-01 2020-04-08 Compugen Ltd. Triple combination antibody therapies
WO2020081634A2 (en) * 2018-10-16 2020-04-23 George Mason Research Foundation, Inc. Compositions and methods for modulation of extracellular vesicle release and treatment of neurological disorders
US11180534B1 (en) 2021-06-04 2021-11-23 Morehouse School Of Medicine Compositions and methods for treating SARS-CoV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
FR2771640B1 (fr) * 1997-12-03 2000-02-11 Inst Nat Sante Rech Med Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
EP1455816A4 (en) * 2000-10-19 2007-03-28 Epimmune Inc HLA CLASS I AND II BINDING PEPTIDES AND THEIR USE
US20030229906A1 (en) * 2002-04-15 2003-12-11 Gelman Irwin H. Methods and compositions for the treatment of disorders of HIV infection
EP1605972A2 (en) * 2003-03-26 2005-12-21 Cytos Biotechnology AG Hiv-peptide-carrier-conjugates

Also Published As

Publication number Publication date
JP2012529293A (ja) 2012-11-22
EP2440570B1 (en) 2013-08-14
US20130123202A1 (en) 2013-05-16
US20140005117A1 (en) 2014-01-02
US8563506B2 (en) 2013-10-22
EP2440570A4 (en) 2012-04-18
WO2010144231A3 (en) 2011-04-21
US20130018002A1 (en) 2013-01-17
WO2010144231A2 (en) 2010-12-16
CN102482325A (zh) 2012-05-30
US20140121170A2 (en) 2014-05-01
CA2761121A1 (en) 2010-12-16
CN102482325B (zh) 2015-01-07
US8871708B2 (en) 2014-10-28
US8431530B2 (en) 2013-04-30
US8476237B2 (en) 2013-07-02
EP2440570A2 (en) 2012-04-18
US20130018003A1 (en) 2013-01-17
US8551943B2 (en) 2013-10-08
US20100317566A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
IL267342A (en) Antibodies and preparations containing them for the treatment of cancer
HK1167662A1 (en) Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
HK1217900A1 (zh) 用於預防或治療眼科病症的方法和組合物
EP2473054A4 (en) COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA
IL218987A0 (en) Methods and compositions for treating cancer
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
IL251083B (en) Compounds and preparations for the treatment of cancer
HK1159498A1 (en) Methods and compositions for the treatment of cancer
EP2558085A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
HK1166305A1 (zh) 用於治療炎症的組合物及方法
EP2504428A4 (en) METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING
EP2419136A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2340027A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
ZA201106577B (en) Compounds and compositions for cognition-enhancement,methods of making,and methods of treating
EP2437738A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2635273A4 (en) ISOFLAVONOID COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2391211A4 (en) METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER
GB0917745D0 (en) Compositions for the prevention or treatment of migraine
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2608794A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBESITY
EP2480099A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES